Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017047 |
---|---|
Receipt number | R000019436 |
Scientific Title | A randomized, open-label clinical trial on the efficacy of blonanserin and olanzapine in patients with schizophrenia and dopamine supersensitivity psychosis |
Date of disclosure of the study information | 2015/04/10 |
Last modified on | 2020/07/20 14:29:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/04/05 00:21:36 | ||
2 | Update | 2015/11/05 09:23:12 | Recruitment status |
|
3 | Update | 2016/10/20 10:08:54 | Primary outcomes Primary outcomes |
|
4 | Update | 2018/04/09 11:42:16 | Randomization unit |
|
5 | Update | 2018/04/09 11:45:38 | Name of primary person or sponsor Organization |
|
6 | Update | 2018/04/09 11:46:57 | Recruitment status |
|
7 | Update | 2019/03/31 20:43:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/03/31 20:44:43 | Number of participants that the trial has enrolled |
|
9 | Update | 2019/03/31 20:53:14 | Recruitment status Date of IRB Last follow-up date Date trial data considered complete |
|
10 | Update | 2020/07/20 14:29:33 | Key secondary outcomes Key secondary outcomes |